Concomitant Alzheimer's disease (AD) pathology is observed in Lewy body diseases (LBD), but the clinical impact is unknown. Only a few biomarker studies in LBD exist and have included small cohorts from single centers.
Cerebrospinal Fluid Alzheimer's Disease Biomarkers Across the Spectrum of Lewy Body Diseases: Results from a Large Multicenter Cohort
BONANNI, Laura;
2016-01-01
Abstract
Concomitant Alzheimer's disease (AD) pathology is observed in Lewy body diseases (LBD), but the clinical impact is unknown. Only a few biomarker studies in LBD exist and have included small cohorts from single centers.File in questo prodotto:
| File | Dimensione | Formato | |
|---|---|---|---|
|
van Steenoven (2016) Cerebrospinal Fluid Alzheimers Disease Biomarkers Across the Spectrum of Lewy Body Diseases Results from a Large Multicenter Cohort.pdf
Solo gestori archivio
Descrizione: Articolo Principale
Tipologia:
Documento in Post-print
Dimensione
205.83 kB
Formato
Adobe PDF
|
205.83 kB | Adobe PDF | Visualizza/Apri Richiedi una copia |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
